- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 36.44M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 36.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 36.89M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $176 |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $1.31K |
| Capex | Q1 2026 · Mar 31, 2026 | $3.92K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $208 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.56K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$4.67K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $15.86M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $44.6M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $26.43M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $94.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $103.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $232.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $248.25M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $269.2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $276.8M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $71.72M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $43.41M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $102.66M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $103.28M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $170.02M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $176.86M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $335.47M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $351.53M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.67M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $9.2M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.7M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $5.44M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.65M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.88M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.17M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$5.28M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $7.19M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $9.36M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $39.01M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $35.36M |